Leading insights With Heart

At Parexel, patients inspire us to deliver better clinical trials ­­— and to drive forward the latest drug development innovations. Access the insights you need to make an impact.

Article

Five strategies for meeting the requirements of Project Optimus and ...

Podcast

Driving change in Cell & Gene Therapies: Key learnings from the SITC ...

Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.

Blog

Taking a Proactive, Preventive Approach to Data Privacy in Clinical ...

Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.

Playbook

Where better medicines begin

In this eBook, we share our best thinking on where better medicines begin, focusing on four early-stage imperatives.

Video

Part One: Gaps to fill with diversity and inclusion in clinical trials

In part one of this four-part conversation, Parexel’s Clare Grace, Chief Patient Officer, has an open discussion with patient advocate Yasmeem Watson, caregiver Ila Gangotra and Fabian Sandoval, M.D.,

Podcast

Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical ...

In this second episode in the Decentrally Speaking series, we will be discussing how pharmaceutical depots are evolving their services and operations to support both sites and patients as a...

Playbook

The upward trend of FSP outsourcing

In this second episode in the Decentrally Speaking series, we will be discussing how pharmaceutical depots are evolving their services and operations to support both sites and patients as a...

Article

Innovative modeling method could speed patient access to critical IO ...

A team of researchers has implemented a groundbreaking method for modeling survival rates in patients with metastatic cancer — an approach that could expedite patient access to novel, much-needed therapies. The team, which includes six Parexel ...